Ubs Group Ag Gh Research PLC Transaction History
Ubs Group Ag
- $397 Billion
- Q1 2024
A detailed history of Ubs Group Ag transactions in Gh Research PLC stock. As of the latest transaction made, Ubs Group Ag holds 209 shares of GHRS stock, worth $2,361. This represents 0.0% of its overall portfolio holdings.
Number of Shares
209Holding current value
$2,361% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding GHRS
# of Institutions
36Shares Held
17MCall Options Held
25.5KPut Options Held
19.8K-
Bvf Inc San Francisco, CA10.4MShares$118 Million3.32% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$37.6 Million0.57% of portfolio
-
Verition Fund Management LLC Greenwich, CT1.13MShares$12.8 Million0.09% of portfolio
-
Cormorant Asset Management, LP Boston, MA593KShares$6.7 Million0.36% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA573KShares$6.47 Million2.15% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $588M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...